↓ Skip to main content

Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities

Overview of attention for article published in Frontiers in Pharmacology, January 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#49 of 19,994)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
17 news outlets
blogs
2 blogs
twitter
197 X users
patent
1 patent
facebook
7 Facebook pages

Citations

dimensions_citation
108 Dimensions

Readers on

mendeley
396 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities
Published in
Frontiers in Pharmacology, January 2019
DOI 10.3389/fphar.2018.01521
Pubmed ID
Authors

Dana Barchel, Orit Stolar, Tal De-Haan, Tomer Ziv-Baran, Naama Saban, Danny Or Fuchs, Gideon Koren, Matitiahu Berkovitch

X Demographics

X Demographics

The data shown below were collected from the profiles of 197 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 396 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 396 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 50 13%
Student > Master 38 10%
Researcher 31 8%
Student > Ph. D. Student 30 8%
Student > Doctoral Student 24 6%
Other 71 18%
Unknown 152 38%
Readers by discipline Count As %
Medicine and Dentistry 58 15%
Psychology 29 7%
Neuroscience 24 6%
Pharmacology, Toxicology and Pharmaceutical Science 20 5%
Biochemistry, Genetics and Molecular Biology 19 5%
Other 75 19%
Unknown 171 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 281. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 October 2023.
All research outputs
#128,564
of 25,711,194 outputs
Outputs from Frontiers in Pharmacology
#49
of 19,994 outputs
Outputs of similar age
#2,588
of 449,089 outputs
Outputs of similar age from Frontiers in Pharmacology
#1
of 334 outputs
Altmetric has tracked 25,711,194 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 19,994 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 449,089 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 334 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.